MedWatch

Sonova downgrades to lower end of guidance after difficult quarter

Hearing aid giant Sonova has lowered its expectations for 2022 after the second quarter of its accounting year, which other hearing firms also found to be challenging.

Photo: Sonova / PR

The world’s largest hearing aid manufacturer, Sonova, has had a difficult second quarter of its 2022/2023 accounting year, and generally, a tough H1.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs